2023
DOI: 10.1038/s41591-023-02268-w
|View full text |Cite
|
Sign up to set email alerts
|

Genomics of perivascular space burden unravels early mechanisms of cerebral small vessel disease

Abstract: Perivascular space (PVS) burden is an emerging, poorly understood, magnetic resonance imaging marker of cerebral small vessel disease, a leading cause of stroke and dementia. Genome-wide association studies in up to 40,095 participants (18 population-based cohorts, 66.3 ± 8.6 yr, 96.9% European ancestry) revealed 24 genome-wide significant PVS risk loci, mainly in the white matter. These were associated with white matter PVS already in young adults (N = 1,748; 22.1 ± 2.3 yr) and were enriched in early-onset le… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
12
0
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
2
1

Relationship

2
7

Authors

Journals

citations
Cited by 36 publications
(20 citation statements)
references
References 80 publications
(117 reference statements)
0
12
0
1
Order By: Relevance
“…In terms of population characteristics, application and method development studies shared similar distribution (i.e., proportion). Median sample size of PVS application studies was N = 161 (IQR = 482.5), with two multicentre epidemiological studies with sample sizes greater than 30,000 (Evans et al, 2023; Duperron et al, 2023) and five with more than 1,000. Broad population type and age-groupings used in application studies compared to method development and improvement studies are presented in Tables 3 and 4, respectively.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…In terms of population characteristics, application and method development studies shared similar distribution (i.e., proportion). Median sample size of PVS application studies was N = 161 (IQR = 482.5), with two multicentre epidemiological studies with sample sizes greater than 30,000 (Evans et al, 2023; Duperron et al, 2023) and five with more than 1,000. Broad population type and age-groupings used in application studies compared to method development and improvement studies are presented in Tables 3 and 4, respectively.…”
Section: Resultsmentioning
confidence: 99%
“…There were significant differences in PVS volume fraction across racial/ethnic groups. (Duperron et al, 2023) Investigate GWAS associations of SVD markers. Only 2/18 cohorts applied a quantitative approach to score PVS burden automatically, which was later dichotomised on the top quartile for uniformity with the rest of the cohorts.…”
Section: Lbc1936 N = 540mentioning
confidence: 99%
“…The PVS data in European populations were obtained from a meta-analysis of 18 cohorts, including 9,317 case and 29,281 control individuals for WM-PVS, 8,950 case and 29,953 control individuals for BG-PVS, and 9,163 case and 29,708 control individuals for HIP-PVS (Duperron et al, 2023). PVSs were defined as fluid-filled spaces with the same signal as the cerebrospinal fluid and no high signal rim on T2-weighted or FLAIR sequences.…”
Section: Methodsmentioning
confidence: 99%
“…15 The outcome dataset was composed of the most recent GWASs of each cSVD phenotype: lacunar stroke (6030 cases and 248 929 controls), WMH volume (N=48 454), CMBs (N=25 862), and PVSs (white matter [WM] PVSs, N=38 598; basal ganglia (BG) PVSs, N=38 903; and hippocampal PVSs, N=38 871). [16][17][18][19] 25(OH) D concentration was mostly measured at the initial assessment visit of the UK Biobank, and rank-based inverse-normal transformation was applied. Information on the month of assessment was included as a covariate, taking into account the well-known seasonal variation associated with 25(OH)D concentration, 20 in addition to information on supplement intake.…”
Section: Datamentioning
confidence: 99%